UNVERIFIEDSingle Source
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Stat News|4/1/2026
NN
Novo Nordisk
24 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
12
Activity (Last 30 Days)
1
1
2026-03-192026-04-01
Top Publishers
Stat News11 stories
Variety1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s next-gen obesity drug stumbles in comparison study
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says
Stat News|2/9/2026
UNVERIFIEDSingle Source
Wegovy Takes to Super Bowl With Sizable Commercial to Spur Visions of Weight Loss
Variety|2/6/2026
UNVERIFIEDSingle Source
Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk sees lower sales, profits as Wegovy faces growing competition
Stat News|2/3/2026